Terms: = Lung cancer AND CD79B, ENSG00000007312, 974, P40259, IGB, B29 AND Staging
4 results:
1. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
[TBL] [Abstract] [Full Text] [Related]
2. The impact of pathology grossing protocol measures to improve pathologic nodal staging in lung cancer.
Ta R; Bozovic G; Wilson JL; Bankier AA; VanderLaan PA
Cancer Treat Res Commun; 2021; 29():100488. PubMed ID: 34856512
[TBL] [Abstract] [Full Text] [Related]
3. 68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis.
Deppen SA; Blume J; Bobbey AJ; Shah C; Graham MM; Lee P; Delbeke D; Walker RC
J Nucl Med; 2016 Jun; 57(6):872-8. PubMed ID: 26769864
[TBL] [Abstract] [Full Text] [Related]
4. A prediction model for N2 disease in T1 non-small cell lung cancer.
Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
[TBL] [Abstract] [Full Text] [Related]